2016

We have long been vocal proponents of Continuing Medical Education (CME) and the benefits it provides to both the medical…

Pharmaceutical and life sciences companies have long used detailing as a way to effectively communicate the benefits and…

As you may recall, we have previously written about ballot initiatives in California and Ohio that are attempting to…

Breaking months of silence on Open Payments data, Centers for Medicare and Medicaid Services (CMS) updated some of the…

With the next filing period for spend data under the Sunshine Act coming up quickly, Ned Mumtaz and Brian Dahl are…

 Earlier this year the FDA announced its intention to issue a rule on fixed-dose combinations and co-packaged products. On…

Once again, the fact that the pharmaceutical industry helps financially support continuing medical education programs is…

During November's American Medical Association (AMA) House of Delegates (HOD) meeting in November, many resolutions and…

The Accreditation Council for Continuing Medical Education (ACCME) has opened a public comment period for their recent…

The Department of Health and Human Services recently released their semi-annual regulatory agenda, a listing of rules…